2023 was a troublesome calendar year with the biopharma field, with quite a few corporations downsizing and restructuring their workforces to stay afloat. You will find indications of Restoration, as mergers and acquisitions picked up through the pharmaceutical and lifestyle sciences sector from the latter part of 2023 and also https://sites.google.com/view/bio-sites/blog